AI assistant
ABBOTT LABORATORIES — Director's Dealing 2004
Aug 5, 2004
29777_dirs_2004-08-05_26f9b548-d236-4352-bfc2-3bb00155f340.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-08-01
Reporting Person: Landgraf John C (Senior Vice President)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 61305 | Direct |
| Common shares without par value | 14238 | Indirect |
| Common shares without par value | 823 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option (right to buy) | $18.3919 | 2005-04-27 | Common shares (9221) | Direct | |
| Option (right to buy) | $27.4328 | 2007-02-13 | Common shares (3941) | Direct | |
| Option (right to buy) | $34.7727 | 2008-02-12 | Common shares (14258) | Direct | |
| Option (right to buy) | $42.4978 | 2009-02-11 | Common shares (15960) | Direct | |
| Option (right to buy) | $32.6111 | 2010-02-10 | Common shares (16917) | Direct | |
| Option (right to buy) | $49.1939 | 2010-10-31 | Common shares (10640) | Direct | |
| Option (right to buy) | $45.4488 | 2011-02-08 | Common shares (42561) | Direct | |
| Option (right to buy) | $45.4723 | 2005-04-27 | Common shares (3074) | Direct | |
| Option (right to buy) | $45.4723 | 2006-02-08 | Common shares (5573) | Direct | |
| Option (right to buy) | $45.4723 | 2007-02-13 | Common shares (7033) | Direct | |
| Option (right to buy) | $53.6250 | 2012-02-14 | Common shares (35468) | Direct | |
| Option (right to buy) | $53.6250 | 2012-02-14 | Common shares (17733) | Direct | |
| Option (right to buy) | $33.2314 | 2013-02-13 | Common shares (21281) | Direct | |
| Option (right to buy) | $33.2314 | 2013-02-13 | Common shares (21281) | Direct | |
| Option (right to buy) | $33.2314 | 2013-02-13 | Common shares (21280) | Direct | |
| Option (right to buy) | $37.4229 | 2007-03-30 | Common shares (3529) | Direct | |
| Option (right to buy) | $43.5128 | 2006-02-08 | Common shares (2532) | Direct | |
| Option (right to buy) | $41.0317 | 2014-02-19 | Common shares (31920) | Direct |
Footnotes
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of July 30, 2004.
F2: Reporting person disclaims beneficial ownership of securities held by his son.
F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.
F4: Employee stock options granted pursuant to the Abbott Laboratories 1991 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.
F5: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.
F6: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 10,640 on 2/20/05; 10,641 on 2/20/06; and 10,639 on 2/20/07.